BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 11134110)

  • 1. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.
    Bender BU; Gutsche M; Gläsker S; Müller B; Kirste G; Eng C; Neumann HP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4568-74. PubMed ID: 11134110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p.
    Benn DE; Dwight T; Richardson AL; Delbridge L; Bambach CP; Stowasser M; Gordon RD; Marsh DJ; Robinson BG
    Cancer Res; 2000 Dec; 60(24):7048-51. PubMed ID: 11156410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
    Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
    JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
    Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN
    Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene.
    Brauch H; Hoeppner W; Jähnig H; Wöhl T; Engelhardt D; Spelsberg F; Ritter MM
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4101-4. PubMed ID: 9398721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.
    Eng C; Crossey PA; Mulligan LM; Healey CS; Houghton C; Prowse A; Chew SL; Dahia PL; O'Riordan JL; Toledo SP
    J Med Genet; 1995 Dec; 32(12):934-7. PubMed ID: 8825918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma.
    Koch CA; Huang SC; Zhuang Z; Stolle C; Azumi N; Chrousos GP; Vortmeyer AO; Pacak K
    Oncogene; 2002 Jan; 21(3):479-82. PubMed ID: 11821960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.
    Woodward ER; Eng C; McMahon R; Voutilainen R; Affara NA; Ponder BA; Maher ER
    Hum Mol Genet; 1997 Jul; 6(7):1051-6. PubMed ID: 9215674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic tests in oncology practice with emphasis on the RET oncogene and VHL tumor suppressor gene].
    Nesković G; Stanojević B; Palmar I; Dimitrijević B
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():52-7. PubMed ID: 12584999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity on the short arm of chromosome 3 in sporadic, von Hippel-Lindau disease-associated, and familial pheochromocytoma.
    Zeiger MA; Zbar B; Keiser H; Linehan WM; Gnarra JR
    Genes Chromosomes Cancer; 1995 Jul; 13(3):151-6. PubMed ID: 7669733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Array-comparative genomic hybridization in sporadic benign pheochromocytomas.
    van Nederveen FH; Korpershoek E; deLeeuw RJ; Verhofstad AA; Lenders JW; Dinjens WN; Lam WL; de Krijger RR
    Endocr Relat Cancer; 2009 Jun; 16(2):505-13. PubMed ID: 19153209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma.
    Crossey PA; Eng C; Ginalska-Malinowska M; Lennard TW; Wheeler DC; Ponder BA; Maher ER
    J Med Genet; 1995 Nov; 32(11):885-6. PubMed ID: 8592333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.
    Khosla S; Patel VM; Hay ID; Schaid DJ; Grant CS; van Heerden JA; Thibodeau SN
    J Clin Invest; 1991 May; 87(5):1691-9. PubMed ID: 2022740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
    Moley JF; Brother MB; Fong CT; White PS; Baylin SB; Nelkin B; Wells SA; Brodeur GM
    Cancer Res; 1992 Feb; 52(4):770-4. PubMed ID: 1346584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1.
    Opocher G; Conton P; Schiavi F; Macino B; Mantero F
    Fam Cancer; 2005; 4(1):13-6. PubMed ID: 15883705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity on the short arm of chromosomes 1 and 3 in sporadic pheochromocytoma and extra-adrenal paraganglioma.
    Vargas MP; Zhuang Z; Wang C; Vortmeyer A; Linehan WM; Merino MJ
    Hum Pathol; 1997 Apr; 28(4):411-5. PubMed ID: 9104939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
    Prowse AH; Webster AR; Richards FM; Richard S; Olschwang S; Resche F; Affara NA; Maher ER
    Am J Hum Genet; 1997 Apr; 60(4):765-71. PubMed ID: 9106522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases.
    Hofstra RM; Stelwagen T; Stulp RP; de Jong D; Hulsbeek M; Kamsteeg EJ; van den Berg A; Landsvater RM; Vermey A; Molenaar WM; Lips CJ; Buys CH
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2881-4. PubMed ID: 8768845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.